Related content

Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?

By Dottorini Massimo  

Clinical and Translational Imaging, Vol. 1, Iss. 3, 2013-06 ,pp. : 205-216

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of risk for symptomatic sialadenitis by post-therapeutic dual ¹³¹I scintigraphy in patients with differentiated thyroid cancer

By Lee Sang   Lee Jeong   Kim Shin   Han Seon   Bae Won  

Annals of Nuclear Medicine, Vol. 27, Iss. 8, 2013-10 ,pp. : 700-709

Springer Publishing Company

Access to resources Recommend Favorite

Value of ¹²⁴I-PET/CT in staging of patients with differentiated thyroid cancer

By Freudenberg L.   Antoch G.   Jentzen W.   Pink R.   Knust J.   Görges R.   Müller S.   Bockisch A.   Debatin J.   Brandau W.  

European Radiology, Vol. 14, Iss. 11, 2004-11 ,pp. : 2092-2098

Springer Publishing Company

Access to resources Recommend Favorite

The diagnostic value of ¹²⁴I-PET in patients with differentiated thyroid cancer

By Phan Ha   Jager Pieter   Paans Anne   Plukker John   Sturkenboom M.   Sluiter W.   Wolffenbuttel Bruce   Dierckx Rudi   Links Thera  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 5, 2008-05 ,pp. : 958-965

Springer Publishing Company

Access to resources Recommend Favorite

Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules

By Hurtado-López Luis-Mauricio   Martínez-Duncker Carlos  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1701-1703

Springer Publishing Company

Access to resources Recommend Favorite